- Home
- ATCX vs BFRI Comparison
ATCX vs BFRI Comparison
Compare ATCX & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ATCX | BFRI |
|---|---|---|
| Founded | 2016 | 1997 |
| Country | Brazil | United States |
| Employees | 13 | 94 |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.0M | 16.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ATCX | BFRI |
|---|---|---|
| Price | $2.60 | $1.24 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $13.75 | $2.75 |
| AVG Volume (30 Days) | 10.0K | ★ 328.7K |
| Earning Date | 03-16-2023 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $827,667.00 | $14.36 |
| Revenue Next Year | $166.45 | $16.98 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.57 | $0.57 |
| 52 Week High | $14.01 | $1.27 |
Technical Indicators
Market Signals| Indicator | ATCX | BFRI |
|---|---|---|
| Relative Strength Index (RSI) | 42.88 | 64.44 |
| Support Level | $2.79 | $1.00 |
| Resistance Level | $3.17 | N/A |
| Average True Range (ATR) | 0.18 | 0.06 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 53.33 | 93.93 |
Price Performance
Historical ComparisonAbout ATCX Atlas Critical Minerals Corporation Common Stock
Atlas Critical Minerals Corp is a mineral exploration and development company focused on critical minerals projects and properties in Brazil. The company's portfolio principally includes mineral properties for rare earths, graphite, titanium, copper, uranium, and nickel. It also owns mineral rights for iron ore, quartzite, gold, and diamond properties. The company's project portfolio includes the Alto Paranaiba, Malacacheta, Arcos, Goias, Tocantins, Rio Piracicaba, and other projects.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.